ARTICLE | Clinical News
ADNS-300 System regulatory update
June 11, 2012 7:00 AM UTC
Neurotech said it received CE Mark approval for ADNS-300 System to treat refractory epilepsy. The company hopes to launch the surgically implanted and rechargeable vagus nerve neurostimulator in Europ...